Results 21 to 30 of about 577,051 (308)
End stage renal disease and survival in people with diabetes:a national database linkage study [PDF]
, 2014 © The Author 2014. Published by Oxford University Press on behalf of the Association of Physicians. Funding This work was supported by the Wellcome Trust through the Scottish Health Informatics Programme (SHIP).
, +20 more
core +7 more sources
Risk prediction to inform surveillance of chronic kidney disease in the US Healthcare Safety Net: a cohort study. [PDF]
, 2016 BackgroundThe capacity of electronic health record (EHR) data to guide targeted surveillance in chronic kidney disease (CKD) is unclear. We sought to leverage EHR data for predicting risk of progressing from CKD to end-stage renal disease (ESRD) to help ...
Chertow, Glenn M +5 more
core +2 more sources
An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula [PDF]
, 2016 Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts.
Goldberg, Itzhak D. +3 more
core +5 more sources
Mucocutaneous manifestations and nail changes in patients with end-stage renal disease on hemodialysis. [PDF]
, 2013 Mucocutaneous manifestations are common among patients on hemodialysis (HD). This study was undertaken to determine the prevalence of mucocutaneous manifestations in patients with end-stage renal disease (ESRD) who are on HD.
Azarhoosh, R. +7 more
core +2 more sources
Silicosis and end-stage renal disease
Scandinavian Journal of Work, Environment & Health, 2002 The objective of this study was to determine the incidence of renal disease among workers with silicosis.A population of 1,328 workers with definite silicosis and adequate work history information, drawn from three states with silicosis surveillance systems, was followed.
Kyle, Steenland +3 more
openaire +3 more sources
Adiponectin and end-stage renal disease [PDF]
Hormones, 2016 Adiponectin (ADPN) is an adipokine with significant anti-inflammatory, insulin-sensitizing and anti-atherogenic properties, which is generally associated with a beneficial cardiometabolic profile. Paradoxically, end-stage renal disease (ESRD) is characterized by markedly increased plasma ADPN levels and increased cardiovascular risk.
Anastasia, Markaki +2 more
openaire +2 more sources
Effects of hemodialysis therapy on sit-to-walk characteristics in end stage renal disease patients [PDF]
, 2012 Patients with end stage renal diseases (ESRD) undergoing hemodialysis (HD) have high morbidity and mortality due to multiple causes; one of which is dramatically higher fall rates than the general population.
Abdel-Rahman, Emaad +3 more
core +2 more sources
Nutrition in end-stage renal disease
Kidney International, 1996 In summary, it is evident that malnutrition is highly prevalent in ESRD patients. This is clearly related to multiple factors encountered during the pre-dialysis stage, as well as during maintenance dialysis therapy. A body of evidence highlights the existence of relationship between malnutrition and outcome in this patient population.
Ikizler, T. Alp, Hakim, Raymond M.
openaire +2 more sources
Baclofen-Induced Encephalopathy in End Stage Renal Disease
Case Reports in Medicine, 2015 Baclofen is a highly used centrally acting GABA agonist that continues to be an effective therapy for spasticity and chronic hiccups. The renally dependent excretion determines the circulating concentrations and guides effective dosing to decrease ...
Andrew Meillier +2 more
doaj +1 more source
Penile Calciphylaxis in End Stage Renal Disease
Case Reports in Urology, 2013 Calciphylaxis, better described as “Calcific uremic arteriolopathy” (CUA), involves about 1–4% of hemodialysis patients all around the world with high mortality rates. We describe a rare clinical case of CUA in peritoneal dialysis patient associated with
Vincenzo Barbera +6 more
doaj +1 more source